Status | Study |
Completed |
Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Date: 2014-05-05 Interventions: Drug: Pazopanib plus Gemcitabine |
Recruiting |
Study Name: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum Condition: Retroperitoneal Liposarcoma Retroperitoneal Leiomyosarcoma Date: 2013-07-17 Interventions: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |
Active, not recruiting |
Study Name: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma Date: 2012-08-06 Interventions: Drug: Trabectedin Type=exact n |
Completed |
Study Name: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Condition: Recurrent Uterine Corpus Sarcoma Uterine Corpus Leiomyosarcoma Date: 2012-07-08 Interventions: Drug: Alisertib Given PO |
Recruiting |
Study Name: Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Condition: Stage I Uterine Sarcoma Uterine Corpus Leiomyosarcoma Date: 2012-02-11 Interventions: Other: Clinical Observation Pa |
Completed |
Study Name: Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas Condition: Leiomyosarcoma Liposarcoma Date: 2011-08-29 Interventions: Drug: Gemcitabine + Trabectedin Combination therapy of gemcitabine and trabectedin |
Recruiting |
Study Name: Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas Condition: Leiomyosarcoma Date: 2011-08-10 Interventions: Drug: pazopanib + gemcitabine pazopanib tablets (200mg) per os, 800mg/day continuously gemcitabine IV, 2 |
Completed |
Study Name: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma Condition: Advanced Liposarcoma or Leiomyosarcoma Date: 2011-04-26 Interventions: Drug: Trabectedin Type=exactly |
Active, not recruiting |
Study Name: Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Condition: Recurrent Uterine Corpus Sarcoma Uterine Corpus Leiomyosarcoma Date: 2010-10-12 Interventions: Drug: Ixabepilone Given IV |
Completed |
Study Name: Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma Condition: Leiomyosarcoma Date: 2009-03-04 Interventions: Drug: letrozole Taken orally once a day continuously |